Patents by Inventor Elena Gonzalez-Rey

Elena Gonzalez-Rey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases
    Patent number: 11365208
    Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: June 21, 2022
    Assignee: Consejo Superior De Investigaciones Cientificas
    Inventors: Juan Carlos Morales Sánchez, Pablo Peñalver Puente, Efres Belmonte Reche, Elena González Rey, Maria Luisa Mateos Martin
  • USES OF MESENCHYMAL STEM CELLS
    Publication number: 20220088084
    Abstract: The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS.
    Type: Application
    Filed: October 8, 2021
    Publication date: March 24, 2022
    Applicants: Consejo Superior de Investigaciones Cientificas, TiGenix, S.A.U., Universidad de Sevilla
    Inventors: Mario DELGADO, Elena GONZALEZ-REY, Dirk BÜSCHER
  • SILYLATED DERIVATIVES OF RESERVATROL AND THE USE THEREOF IN NEURODEGENERATIVE, NEUROLOGICAL OR INFLAMMATORY DISEASES
    Publication number: 20190284213
    Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.
    Type: Application
    Filed: November 23, 2017
    Publication date: September 19, 2019
    Inventors: Juan Carlos Morales Sánchez, Pablo Peñalver Puente, Efres Belmonte Reche, Elena González Rey, María Luisa Mateos Martín
  • USES OF MESENCHYMAL STEM CELLS
    Publication number: 20120027730
    Abstract: The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS.
    Type: Application
    Filed: August 3, 2009
    Publication date: February 2, 2012
    Applicants: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, CELLERIX SA
    Inventors: Mario Delgado, Elena Gonzalez-Rey, Dirk Büscher